3104NSC Chap.8 ADME, Pharmacokinetics and Pharmacodynamics

ADME, Pharmacokinetics and Pharmacodynamics

Define ADME

ADME, Pharmacokinetics and Pharmacodynamics places ADME, pharmacokinetics and pharmacodynamics on a target-to-patient evidence chain.

The practical task is to trace how one change in clearance or bioavailability alters exposure and expected effect; each step must connect the therapeutic need and biological target to molecular properties, ADME, exposure, effect and an appropriate formulation or delivery choice.

Place ADME at its correct stage in the development chain.

Define the evidential role of ADME — therapeutic need, target evidence, candidate property, exposure observation, effect measure, delivery constraint or synthesis claim — and separate what is measured from what remains inferred.

State whether pharmacokinetics supplies a mechanism, comparison, prediction or evidence synthesis, then trace only the downstream molecular-property, ADME, exposure or effect changes it can support.

In ADME, Pharmacokinetics and Pharmacodynamics, that distinction keeps pharmacokinetics from being mistaken for a molecular mechanism when it instead names an assessment architecture, seminar or evidence dossier.

Use pharmacodynamics as a discriminating test or control.

Specify which assay, pharmacokinetic observation, pharmacodynamic response, validation result or evidence-synthesis finding would support pharmacodynamics, and name an alternative result that would weaken it.

For the application — trace how one change in clearance or bioavailability alters exposure and expected effect — connect target evidence to a candidate, formulation or delivery choice without skipping the exposure-effect relationship.

Finish ADME, Pharmacokinetics and Pharmacodynamics by stating which experiment or measurement should be run next and why its result could change the interpretation attached to pharmacodynamics.

Build an evidence chain for ADME: therapeutic need and target; candidate property or interaction; ADME and exposure; observed effect; formulation or delivery constraint.

Place pharmacokinetics and pharmacodynamics at the step they actually test. A candidate described through ADME is not advanced merely because every stage can be named; the links to pharmacokinetics and pharmacodynamics require compatible evidence.

Trace pharmacokinetics

Run a pharmacokinetics counterfactual check.

Change one assumption or molecular property associated with pharmacokinetics while holding the relevant target and dose conditions stable, then predict the direction of exposure and effect where that prediction is applicable.

Compare it with the pharmacodynamics evidence; a mismatch between pharmacokinetics and pharmacodynamics may reveal an incorrect mechanism, missing evidence, off-target activity or a delivery limitation.

Rehearse ADME, Pharmacokinetics and Pharmacodynamics from target to patient rather than as a list of terms.

Starting with ADME, state the target or therapeutic need, the property or evidence under study, the relevant ADME consequence, the exposure-effect observation and the formulation or delivery implication.

Mark the first unsupported transition between pharmacokinetics and pharmacodynamics, and repair it before adding another candidate claim.

A complete response should make the task visible before the detail: identify what must be decided, define the relevant terms, connect the evidence to pharmacokinetics, and use pharmacodynamics to test the result.

The final sentence about pharmacodynamics should answer the question actually asked rather than merely repeat the topic.

The controlling limit is specific: The same plasma concentration can produce different effects when target sensitivity, disease state or active metabolites differ.

Keep that pharmacodynamics limit beside the worked example, because it separates a careful 3104NSC answer from one that sounds confident but claims more than the task or evidence supports.

For revision, retrieve ADME, pharmacokinetics and pharmacodynamics without notes, explain their relationship aloud, then complete a changed version of the application: trace how one change in clearance or bioavailability alters exposure and expected effect.

Record the first failed pharmacokinetics reasoning move and repair it before attempting another case.

What this chapter covers

• 01

  ADME

• 02

  pharmacokinetics

• 03

  pharmacodynamics

• 04

  Applying ADME

• 05

  Limits of pharmacokinetics and pharmacodynamics

Worked example: ADME, Pharmacokinetics and Pharmacodynamics

Key terms

ADME

The linked processes of absorption, distribution, metabolism and excretion that determine drug exposure in the body. Use this definition when the task is to trace how one change in clearance or bioavailability alters exposure and expected effect.

pharmacokinetics

The quantitative study of drug concentration over time as the body absorbs, distributes, metabolises and eliminates a dose. Use this definition when the task is to trace how one change in clearance or bioavailability alters exposure and expected effect.

pharmacodynamics

The relationship between drug concentration at the site of action and the resulting biological or clinical effect. Use this definition when the task is to trace how one change in clearance or bioavailability alters exposure and expected effect.

ADME, Pharmacokinetics and Pharmacodynamics FAQ

Assessment move

Reconstruct the relationship among ADME, pharmacokinetics and pharmacodynamics; complete the chapter application without notes; then test the result against this limit: The same plasma concentration can produce different effects when target sensitivity, disease state or active metabolites differ.

Working through ADME, Pharmacokinetics and Pharmacodynamics in 3104NSC? Sia is AskSia’s AI Biomedical Science tutor — ask any 3104NSC ADME, Pharmacokinetics and Pharmacodynamics question and get a clear, step-by-step explanation grounded in how 3104NSC is taught and assessed. Read this chapter free, then take your hardest questions to Sia.